Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  3.75 8.57% 47.50 3,221,376 16:35:09
Bid Price Offer Price High Price Low Price Open Price
47.50 48.00 48.00 43.75 43.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -7.24 -4.46 97.0
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:09 O 200,000 47.67 GBX

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
16/7/201916:36FUTURA a winner for 20155,583
08/7/201909:08one million2
21/1/201909:54www.bluediamondcondom.com59
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414
21/6/201608:43fum reality1

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:36:3947.67200,00095,330.00O
15:35:0947.5018,0008,550.00UT
15:29:1547.586,7983,234.15O
15:29:0847.582,000951.50O
15:27:3047.991,000479.90O
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

DateSubject
16/7/2019
09:20
Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 43.75p.
Futura Medical Plc has a 4 week average price of 24p and a 12 week average price of 17.25p.
The 1 year high share price is 48p while the 1 year low share price is currently 5.50p.
There are currently 204,660,267 shares in issue and the average daily traded volume is 693,397 shares. The market capitalisation of Futura Medical Plc is £97,213,626.83.
16/7/2019
16:19
qs99: Does look very strong buying, each time it gets sold down, up it goes again. Let's see what unfolds, but last 3 weeks right angled increase and doubling of share price suggests something worthwhile IMO! DYOR
08/7/2019
11:13
j777j: I would imagine the share price will levitate back towards the 60p levels as phase 3 results and the pain gel UK marketing approval edge ever closer. Gla
03/7/2019
07:29
j777j: What an opportunity that was. Especially when the Ceo two days ago said they have had "Huge interest." Then look at the Almost $13 billion marketplaces they are addressing,with the med and pain gels. Another judge of success to me, will be when the share price exceeds the 90p all time highs set back in 2016,therefore redeeming all long term shareholders. Given Liberum's maximum success scenario of 140p,90p is quite achievable. So hopefully everyone at least gets their money back.
19/6/2019
07:49
j777j: Ties in nicely with this "Futura Medical PLC’s (LON:FUM) data from a Phase 3 trial of its MED2005 erectile dysfunction treatment could drive the share price up over 500% according to analysts at Liberum Capital, who on Monday initiated the stock with a ‘buy’ rating and 60p target price. In its initiation note, the ‘house’ broker for the AIM-listed pharma firm said they expected positive data from the Phase 3 trial for MED2002, which is expected to be delivered by December this year." So maybe November we will know the outcome.
23/5/2019
12:16
loobrush: New broker -its good news as they can offer much more than previous one and will want toshow how they can do this and get the share price back to a sensible level. In my view some good news is due and they want the new broker to deal with this. Could well be approval for use of the pain products which is due anytime now. Rhat would give abig lift to the share price.
14/1/2019
11:00
bioking: If you guys want the stock to make bigger moves then please put your shares on high GTC sell order like 50p this helps to prevent your shares from being shorted and more important your shares will not be available on the market so if all shareholders doing that then it would help this stock to make bigger jumps in share price on good news. thank you hxxp://www.contracts-for-difference.com/Borrowing-lending-shares.html Q:What can you do to prevent your shares holdings from being shorted? A: Now what can the average personal investor do to stop their own shares being shorted, as believe me your own broker, if approached, WILL sell your own shares that they hold on your behalf as a nominee account. There are two things you can do, the first is to certificate them but this is not obviously to everyone’s advantage but the alternative solution is simple. All you do is to phone your broker and put an order in saying that you wish to place your shares for sale at, for arguments sake, double today’s price. As they are ‘on order’ they cannot be lent out by your broker and in turn you are reducing the amount of ‘free shares’ out there that can be used for shorting purposes. And don’t forget to move your limit order up when the price starts to recover, then, that way your shares can’t be shorted – not much but helps :D. Although an individual personal investor will not normally have enough shares to halt a concerted shorting attack, if a large number of holders did this it would reduce the overall amount of shares that they could get their hands on. In my opinion well worth doing if not only for the knowledge that your own shares cannot and will not be used in a short attack against the very share that you own.
09/1/2019
15:14
lbo: Such a fantastic opportunity that the partner who was supposedly in advanced discussions in March 2018 when the share price was 40p and then completely disappeared and now even at the supposed bargain of 10p has not reappeared with a bid. Never mind even buying shares in the 7p fundraising which was undersubscribed.Mr Barder then backtracked in September and October 2018 and said that raising funds and carrying out phase 3 would add 50% more value to the Med2002 licensing deal yet all the while the share price collapsed from 40p to 7p. So Futura management now need to add 400% in share price value to just get it back to the share price where they claimed they were in advanced discussions with a partner and then claimed by raising funds and completing phase 3 they would add 50% more value to the licensing deal.
02/3/2018
15:12
j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here.
07/6/2017
09:33
mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4
06/6/2017
22:59
jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here.
Futura Medical share price data is direct from the London Stock Exchange
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190716 16:29:22